Pre-conference symposium: Ready, set, translate!
Symposium will investigate the strengths and weaknesses of available data for classes of interventions or targets.
Stroke in the Lab World: Investigational Targets in Ischemic Stroke: Ready, Set, Translate!
9 a.m.-5 p.m. | Tuesday, Feb. 4 | Room 152
After the success of last year’s Stroke in the Lab World focusing on multicenter preclinical trials, this year's all-day symposium puts the spotlight on a broad range of promising investigational targets in stroke therapy.
Led by Johannes Boltze, professor of neuroscience at the University of Warwick, Emily Sena, professor of metascience and translational medicine at the University of Edinburgh, and Sarah McCann, research group leader at the Charité Universitätsmedizin Berlin, the symposium covers pharmacological, physiological and device interventions. Each speaker will take up a particular class of interventions or targets and provide a systematic unbiased overview of the strengths and weaknesses of the data available, putting it under the lens for readiness for a multicenter preclinical trial and eventual clinical translation.
Each session will start with a poll on which target in that session is the most promising and end with a repeat poll of the same. Each session will also include generous time for a forum with audience participation. At the end of the symposium, we will poll the audience for their top three targets.
The aim of the program is to stimulate broad interest, not only to see what others think about the targets they are interested in, but also to educate themselves about other promising targets out there. With audience engagement, we will parse through targets that may be considered "old pickles" and others that may be controversial.
See the Online Program Planner or more information.
